MyoKardia, Inc. – Trademark Portfolio
Entity Type: 03
MyoKardia, Inc. holds 38 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 35 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 7 trademarks are registered and 11 are pending. Notable registered marks include CAMZYOS, MYOKARDIA, DRIVEN BY THE HEART, and MY CAMZYOS PATIENT SUPPORT. The owner is based in Brisbane, CA.
1000 Sierra Point Parkway
Brisbane, CA 94005
Showing of trademarks Trademarks
Trademark Classifications
MyoKardia, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does MyoKardia, Inc. have?
MyoKardia, Inc. has 38 U.S. trademarks filed with the USPTO. Of these, 7 registered, 11 pending, 20 abandoned.
What trademark classes does MyoKardia, Inc. file in?
MyoKardia, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 36 (Insurance & Financial). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MyoKardia, Inc.'s most well-known trademarks?
MyoKardia, Inc.'s registered trademark portfolio includes well-known marks such as CAMZYOS, MYOKARDIA, DRIVEN BY THE HEART, and MY CAMZYOS PATIENT SUPPORT. These are among 7 currently registered trademarks in the portfolio.
What is MyoKardia, Inc.'s trademark registration success rate?
MyoKardia, Inc. has a 26% trademark registration rate, with 7 out of 27 resolved applications resulting in successful registration. Currently, 11 applications are pending review.